Confronta i metodi
Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.
| EQ-5D× | SF-12 Health Survey× | |
|---|---|---|
| Campo | Misurazione in sanità | Misurazione in sanità |
| Famiglia | Process / pipeline | Process / pipeline |
| Anno di origine≠ | 1990 | 1996 |
| Ideatore≠ | EuroQol Group | John E. Ware Jr., Mark Kosinski, and Susan Keller |
| Tipo≠ | Generic preference-based health utility measure | Brief self-report health status instrument |
| Fonte seminale≠ | Rabin, R., & de Charro, F. (2001). EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343. DOI ↗ | Ware, J. E., Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233. DOI ↗ |
| Alias≠ | EQ-5D-3L, EQ-5D-5L, EuroQol | SF-12v2, Medical Outcomes Study SF-12 |
| Correlati≠ | 5 | 4 |
| Sintesi≠ | The EQ-5D is a standardized, preference-based health utility measure developed by the EuroQol Group in 1990. It combines a descriptive health profile (five dimensions, three or five response levels) with a visual analog scale to quantify overall health status. The instrument has become essential for health economics, clinical trials, and cost-effectiveness analysis worldwide. | The SF-12 is a brief, 12-item version of the SF-36 health survey developed by Ware, Kosinski, and Keller in 1996. Designed to reduce respondent burden while maintaining psychometric validity, it has become the standard instrument for large-scale surveys, epidemiological studies, and health outcomes research where administration time is critical. |
| ScholarGateInsieme di dati ↗ |
|
|